On July 11th, Grant Blevins of FCA Venture Partners in Nashville Tennessee, returned to OBIO via webinar to give his second workshop on digital health. Grant focused on the "Why, When, & How Much" that early stage companies should consider when raising capital.
In the latest issue of Biotechnology Focus, OBIO President and CEO Gail Garland contributed a special report.
Anchor Companies and 'Sticky Capital': A prescription for attracting bioscience investment to Ontario
Gail Garland, President and CEO of OBIO, travelled to San Diego for BIO 2017, one of the largest annual conventions in the biotechnology industry.
Enjoy this weeks blog on Finding the Right Candidate by Sean Peel, H2BB™ Business Development Manager & Ryan Ball, H2BB™ Program Associate.
On May 12th, Grant Blevins and Andrew Bouldin of FCA Venture Partners, of Nashville, Tennessee, gave a workshop on the financing landscape of the digital health industry. FCA Venture Partners provides early stage capital for innovative digital health companies focusing on B2B SaaS.
The “Tackling the Anchor Company Challenge Summit”, assembled industry, academic, government and investment leaders committed to working together to create a mandate of action for anchoring health science companies in Ontario.
In 2015, the Ontario Bioscience Innovation Organization convened a working group (‘OBIO Tax Policy Working Group’, OTPWG) of health science industry leaders and tax experts from academia and the private sector to examine Canada’s tax incentives and their effectiveness in stimulating growth in the health science industry.
Enjoy this week's blog by Sean Peel, OBIO's H2BB™ Business Development Manager.
Enjoy Part II of the RESI Recap series authored by OBIO's Klaus Fiebig, VP Strategic Programs
OBIO's own VP Strategic Programs, Klaus Fiebig, shares his impressions and advice garnered from RESI on MaRS last week highlighting some of the trends and sentiments about early stage fundraising.
OBIO kicked off its 2017 Capital Access Advisory Program (CAAP®) on March 29, 2017, hosted at sponsor Norton Rose Fulbright LLP (NRF) Canada, just as Toronto’s first inaugural Health Innovation Week launches
OBIO has provided feedback to the Ministry of Research Innovation and Science on the the Province's request to recruit Ontario's First Chief Science Officer.
The Ontario Bioscience Innovation Organization Leadership Summit Hosts Top Health Science Minds to Define Future of the Industry
The Ontario Bioscience Innovation Organization Announces New Public Relations & Communications Services Member Benefit